Search the Newsreel

Qiagen (QGEN) Beats Q2 Earnings and Revenue Estimates

Qiagen (QGEN) exceeded Q2 earnings and revenue estimates, reporting $0.62 per share against a $0.60 consensus and revenues of $535.04 million, surpassing the $527.91 million estimate. Despite the beat, the company's shares have underperformed the S&P 500 year-to-date, and its Zacks Rank of #4 …

Earnings Flash (QGEN) QIAGEN N.V. Reports Q2 Revenue $535.0M, vs. FactSet Est of $527.5M

Earnings Flash (QGEN) QIAGEN N.V. Posts Q2 Adjusted EPS $0.62 per Share, vs. FactSet Est of $0.60

Qiagen meldet stagnierenden Q2-Umsatz und bestätigt Jahresprognose

QIAGEN übertrifft Prognose für das zweite Quartal 2026 dank solider Umsatzzuwächse seiner Wachstumsträger und bestätigt Jahresprognose

QIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year Outlook

Q2 2026 results: Net sales of $535 million unchanged compared with Q2 2025 on a reported basis and at constant exchange rates (CER), exceeding the outlook for an about 2% CER decline Growth pillars deliver about 5% CER growth, led by Sample technologies, QIAcuity …

Janus Henderson Group PLC Makes New Investment in Qiagen N.V. $QGEN

Janus Henderson Group PLC has made a new investment in Qiagen N.V., purchasing 366,661 shares valued at approximately $14.6 million, giving it a 0.18% stake. Other institutional investors have also adjusted their holdings, with institutional ownership of Qiagen reaching 70%. Analyst sentiment for Qiagen …

Qiagen Aktie: Prognose übertroffen

QIAGEN's growth pillars deliver 5% CER growth as U.S. testing falls

QIAGEN NV Revenue Breakdown – BIVA:QIA/N

QIAGEN NV (BIVA:QIA/N) generated 37.68 billion MXN in revenue last year. Its top-performing segment was Diagnostic Solutions, contributing 14.48 billion MXN. The United States was the largest regional contributor, accounting for 18.00 billion MXN of the total revenue.

Release according to Article 40, Section 1 of the WpHG

QIAGEN N.V. has released a notification regarding voting rights, as informed by the AFM. T. Rowe Price Group, Inc. reported a transaction on July 29, 2026, showing a capital interest and voting rights distribution of 4.97% in QIAGEN N.V. The company emphasizes it is …

Segall Bryant & Hamill LLC Lowers Holdings in Qiagen N.V. $QGEN

Segall Bryant & Hamill LLC reduced its stake in Qiagen N.V. by 24.5% in the first quarter, selling 36,110 shares but still retaining 111,177 shares worth approximately $4.45 million. Despite this reduction, other institutional investors like Groupe la Francaise, Janus Henderson Group PLC, Amundi, …

Qiagen NV expected to post earnings of 60 cents a share - Earnings Preview

Qiagen NV is projected to report earnings of 60 cents per share. This information comes from a Refinitiv earnings preview. The full article content is available on TradingView, which aggregates news from various sources including Reuters.

Qiagen N.V. $QGEN Shares Sold by Edgestream Partners L.P.

Qiagen (QGEN) Stock Could Be A Cash Flow Bargain Yet Fair On Earnings

Qiagen NV (QGEN.BRN) Q4 2024 Earnings Report - Results, Call & Slides

Qiagen NV (QGEN.BRN) reported its Q4 2024 earnings, missing the consensus EPS estimate by -CHF0.01 with an actual EPS of CHF0.52. However, the company beat revenue expectations, reporting CHF424.78M against an expected CHF424.66M, marking a 2.36% year-over-year revenue growth. The earnings call and slide …

China Hongqiao Group Stock Climbs 2.1% in Hong Kong

QGEN|Qiagen NV|Price:41.435|Chg%:-0.375

This article provides a detailed analysis of Qiagen NV (QGEN) stock, highlighting its current market trends, real-time quotes, and related analysis. It covers key financial figures, insights into its growth potential and valuation, and analyst ratings, which currently lean towards "Buy." The company's strengths …

Amundi Has $190.50 Million Stake in Qiagen N.V. $QGEN

Amundi increased its stake in Qiagen N.V. by 12.4% in the first quarter, now holding 4.76 million shares valued at $190.5 million, representing 2.31% of the company.

PTA-PVR: QIAGEN N.V.: Veröffentlichung nach § 40 Abs. 1 WpHG

This article announces that QIAGEN N.V. has published a voting rights notification in accordance with § 40 Abs. 1 WpHG, as informed by the AFM on July 29, 2026. The notification details various share and voting rights distributions related to Goldman Sachs Group Inc., …

QIAGEN Number of Employees 2026 | Employee Count & Headcount Data

QIAGEN NV (QGEN) has approximately 5,617 employees worldwide as of March 2026, marking a 6.6% decline from 2023. The company is actively hiring, with 272 job postings in 2026, though new postings per month have decreased. The workforce is primarily concentrated in the United …

Xpress Genomics Joins Parse Biosciences’ Certified Service Provider Network

Stockholm-based service provider adds Evercode to its single cell sequencing offerings SEATTLE, July 29, 2026--(BUSINESS WIRE)--Parse Biosciences, the leading provider of scalable and accessible single cell sequencing, and a QIAGEN company, today announced that Xpress Genomics has joined its Certified Service Provider (CSP) program, …

Qiagen NV (QGEN) Institutional Confidence

Qiagen NV (QGEN) has an institutional shareholding score of 7.00, placing it 80th out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 78.32%, a 4.59% increase quarter-over-quarter. ETHSX is the largest institutional shareholder, holding 980.90K shares, representing …

Analysts Estimate Qiagen (QGEN) to Report a Decline in Earnings: What to Look Out for

Analysts expect Qiagen (QGEN) to report a year-over-year decline in earnings and lower revenues for the quarter ended June 2026, with an expected earnings report date of August 5. The Zacks Earnings ESP for Qiagen is negative (-0.28%) and combined with a Zacks Rank …

Qiagen (QGEN) Projected to Post Quarterly Earnings on Wednesday

Qiagen NV (QGEN) Financial Health: Profitability & Balance Sheet Analysis

The article provides an analysis of Qiagen NV (QGEN)'s financial health, indicating a stable financial status and high operating efficiency with a current financial score of 8.79. The company reported a 1.83% year-over-year increase in quarterly revenue, reaching 492.32M, and a 25.03% year-over-year increase …

Is Qiagen (QGEN) A Bargain On Its Infectious Disease Testing Push?

Qiagen (QGEN) is focusing on infectious disease diagnostics, highlighted by its role in the U.S. cyclosporiasis response and the launch of a new CE-IVDR-certified panel. While the stock has seen a 21.6% return over the last 90 days, its year-to-date and one-year returns are …

Qiagen NV (QGEN) Cash Flow

This article provides a detailed cash flow statement for Qiagen NV (QGEN), covering quarterly and annual data for operating, investing, and financing activities. It also includes key financial metrics such as market cap, P/E ratio, and free cash flow. The report highlights Qiagen NV's …

Troluce Capital Advisors LLC Purchases Shares of 362,500 Qiagen N.V. $QGEN

Troluce Capital Advisors LLC newly acquired 362,500 shares of Qiagen N.V. (NYSE:QGEN) in the first quarter, valued at approximately $14.5 million, making Qiagen its 28th-largest holding and representing 0.18% of Qiagen's stock. Other institutional investors also adjusted their positions, and collectively, institutional investors own …

Sona Asset Management US LLC Invests $8.89 Million in Qiagen N.V. $QGEN

Sona Asset Management US LLC has acquired 222,060 shares of Qiagen N.V. (QGEN) worth $8.89 million, representing a 0.11% stake. Institutional investors collectively own approximately 70% of Qiagen. The company recently reported earnings of $0.54 per share, matching estimates, and increased its annual dividend …

Qiagen NV (QGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Qiagen NV (QGEN), categorizing its income by business segments and geographical regions. It highlights that "Consumables and Related Revenues" constitute the vast majority of its business, and the United States is its largest regional market. The …

UBS Group discloses 2.98% stake in QIAGEN via AFM filing

UBS Group AG has disclosed a 2.98% stake in QIAGEN, held through a combination of ordinary shares, options, swaps, and convertible bonds, according to a notification from the Dutch financial markets regulator AFM. This significant institutional holding highlights investor interest in QIAGEN stock, potentially …

BlackRock Discloses Significant Stake in Qiagen

BlackRock, Inc. and its affiliates have disclosed a substantial stake in Qiagen N.V., totaling 11.66% capital interest and 13.10% voting rights, through ordinary shares and contracts for difference. This significant holding by a global asset manager is expected to influence Qiagen's shareholder structure and …

Qiagen stock trades steady as diagnostics demand supports revenue growth

Qiagen stock shows stable demand for molecular diagnostics, with recent quarterly reports indicating mid-single-digit revenue growth and solid margins despite a challenging life-sciences market. The company focuses on base business growth, recurring revenue streams, and strategic investments in R&D and acquisitions to maintain its …

Bessemer Group Inc. Sells 43,977 Shares of Qiagen N.V. $QGEN

Bessemer Group Inc. significantly reduced its stake in Qiagen N.V. (NYSE:QGEN) by 84.4% in the first quarter, selling 43,977 shares and bringing its total holdings to 8,112 shares worth $324,000. Despite this, several other institutional investors increased their positions in Qiagen, and the company …

BlackRock builds 11.6% stake in Qiagen, lifting voting power to 13%

BlackRock, Inc. has increased its stake in Qiagen to an overall capital interest of 11.61% and voting rights of 13.04%, according to a filing with the Dutch Authority for the Financial Markets. This significant move by one of the world's largest asset managers underscores …